| 000 | 01729 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517054034.0 | ||
| 264 | 0 | _c20160504 | |
| 008 | 201605s 0 0 eng d | ||
| 022 | _a1432-0584 | ||
| 024 | 7 |
_a10.1007/s00277-015-2512-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchneidawind, Dominik | |
| 245 | 0 | 0 |
_aReduced-intensity conditioning with fludarabine and busulfan for allogeneic hematopoietic cell transplantation in elderly or infirm patients with advanced myeloid malignancies. _h[electronic resource] |
| 260 |
_bAnnals of hematology _cJan 2016 |
||
| 300 |
_a115-124 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBone Marrow Diseases _xdiagnosis |
| 650 | 0 | 4 |
_aBusulfan _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSurvival Rate _xtrends |
| 650 | 0 | 4 |
_aTransplantation Conditioning _xmethods |
| 650 | 0 | 4 |
_aTransplantation, Homologous _xmethods |
| 650 | 0 | 4 |
_aVidarabine _xadministration & dosage |
| 700 | 1 | _aFedermann, Birgit | |
| 700 | 1 | _aBuechele, Corina | |
| 700 | 1 | _aHelwig, Andrea | |
| 700 | 1 | _aSchmohl, Jörg | |
| 700 | 1 | _aVogel, Wichard | |
| 700 | 1 | _aFaul, Christoph | |
| 700 | 1 | _aKanz, Lothar | |
| 700 | 1 | _aBethge, Wolfgang A | |
| 773 | 0 |
_tAnnals of hematology _gvol. 95 _gno. 1 _gp. 115-124 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00277-015-2512-y _zAvailable from publisher's website |
| 999 |
_c25300907 _d25300907 |
||